Biologics Financial Sports Medicine Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance byTim AllenMay 7, 2026
Biologics Financial Spine Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance byTim AllenMay 5, 2026
Financial Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results byTim AllenMarch 31, 2026
Financial Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025 byTim AllenMarch 27, 2026
Financial Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results byJosh SandbergMarch 10, 2026
Financial Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025 byTim AllenMarch 10, 2026
Financial Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results byTim AllenMarch 9, 2026
Financial Globus Medical Reports Fourth Quarter and Full Year 2025 Results byTim AllenFebruary 25, 2026